Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,622 across all filing types
Latest filing 2022-10-12 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
天域生态关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of part of idle raised funds temporarily used to supplement working capital. It details the board's approval, the amount repaid, and the plan for remaining funds. There is no financial statement or detailed financial analysis, nor is it a report or presentation. It is a specific update on the use and repayment of raised capital funds. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is short and focused on this financing update, not a full report or regulatory filing.
2022-10-12 Chinese
德恒上海律师事务所关于天域生态环境股份有限公司2022年第三次临时股东大会的法律意见书
Regulatory Filings
2022-10-10 Chinese
天域生态2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the company's third extraordinary general meeting of shareholders in 2022. It includes information about the meeting date, location, attendance, voting results on various proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholder meeting rather than financial results, management changes, or other report types. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a report publication notice, but the actual voting results disclosure.
2022-10-10 Chinese
独立董事关于第三届董事会第四十九次会议相关议案的独立意见
Regulatory Filings
2022-10-09 Chinese
独立董事提名人声明-包满珠
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board, detailing qualifications, legal compliance, and independence criteria. It references regulatory requirements and internal governance rules but does not contain financial data, earnings, or report content. It is not an announcement of a report publication, nor a certification letter. The content fits best under Board/Management Information (MANG) as it concerns board member nomination and related disclosures.
2022-10-09 Chinese
独立董事候选人声明-包满珠
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate confirming qualifications, independence, and compliance with regulatory requirements. It is a formal statement related to board membership candidacy rather than a report, financial statement, or announcement of voting results. It does not contain financial data, audit information, or meeting results. It is not a proxy solicitation or remuneration report. The content fits best under Board/Management Information (MANG) as it pertains to board member nomination and qualifications.
2022-10-09 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.